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RECENTLY Cercek, Cercek and Franklin
(1]974) have shown that changes in the
structuredness of cytoplasmic matrix
(SCM) in human lymphocytes induced
by cancer basic proteins (CaBP) and
phytohaemagglutinin (PHA) can be used
to differentiate patients with malignant
disease from those with non-malignant
disorders or healthy donors. Since the
incidence of gastric cancer is very high
in Japanese (Bockus, 1974) and the
prognosis of gastrectomy in patients with
the early stage ofgastric cancer is reported
to be excellent (Hayashida and Kidokoro,
1969) screening for the detection of the
early stage of gastric cancer by regular
X-ray examination of the stomach is
conducted throughout Japan. To explore
whether the SCM test can be used in the
diagnosis of gastric cancer, we have
performed 2 pilot studies, one involving
33 cases of cancer of the stomach, 15
healthy donors, 12 cases of non-malignant
diseases and 39 cases of other malignant
disorders, the other concentrating on 10
cases of "early stages" of cancer of the
stomach. These were defined as "carci-
noma of the stomach in which the in-
vasion by cancer cells was limited to
the mucosa and/or to submucosa", the
definition being that of the Japanese
Gastroenterological Endoscopy Society in
1962 and of the Japanese Research
Society for Gastric Cancer in 1963. This
definition is widely used in Japan.
All 10 patients were operated on and
confirmed to be in the early stage of
gastric cancer as defined above. Any
cases found to have lymph-node meta-
stasis on operation were excluded, even
if the invasion by cancer cells was limited
to the mucosa and/or submucosa, thus
complying with the definition of early-
stage gastric cancer.
Peripheral lymphocytes were isolated
from heparinized blood (300 i.u. ofheparin
per 10 ml blood). Ten-millilitre aliquots of
blood were rotated in glass vials con-
taining 0-1 g of carbonyl iron powder
at 60 rev/min for 30 min. Vials were
then placed on a magnet for 10 nmin.
Lymphocytes were separated by the
Ficoll-Triosil gradient-density technique
(Harris and Ukaejiofo, 1969). The density
of the gradient was 1-081 at 25°C. The
lymphocytes which band out oIn the
interface were collected, washed twice
with saline, once with Dulbecco's PBS,
and resuspended in Dulbecco's PBS at
the concentration of 6 x 106 cells/ml.
Aliquots of 1 ml of lymphocyte suspen-
sions were incubated at 37°C for 30 min
with 50 ,ug of cancer basic protein (CaBP)
and with 0 1 ml ofa 50 x diluted reagent-
grade PHA (Wellcome Ltd). The CaBP
was extracted from colon cancer tissue
according to published methods (Carnegie,
Caspary and Field, 1973; Dickinson et
al., 1974). Aliquots of 0-2 ml of control
or stimulated lymphocyte suspension were
injected into 3 ml of 2-5 uali fluorescein-
diacetate (FDA) solution in completeSCM TEST FOR GASTRIC CANCER
Dulbecco's PBS (pH 7.4). The suspension
was rapidly transferred into a 1 cm2
cuvette and put into the thermostatted
cuvette holder of the Hitachi MPF-4
fluorescence spectrophotometer fitted with
the polarization accessory. Measurements
were made at 27°C. Details of the SCM
technique were the same as described by
Cercek, Cercek and Ockey (1973) with
the modifications of Cercek and Cercek
(1977).
The sampling and measurements were
performed by T.Y. and Y.H. The calcula-
tion of the results, however, was done by
technicians who did not know the diag-
nosis of the patients. In some cases inter-
mediate SCM values of around 1 were
found, but on repeating the tests even
these fell into a clearly positive or negative
category. The reliability of the results
appears to depend on the quality of the
TABLE 1.-SCM Response of Lymphocytes
from Patients with Stomach Cancer
Age Sex
35 M
43 F
48 M
57 F
68 M
73 M
64 M
58 M
73 M
46 M
57 M
65 M
75 M
41 F
45 M
49 M
58 M
59 F
63 F
55 M
45 M
52 M
58 F
70 M
48 F
71 F
60 M
35 F
38 M
60 M
35 M
41 M
41 M
Diagnosis
Ca (early)
Ca (early)
Ca (early)
Ca (early)
Ca (early)
Ca (advanced)
Ca (advanced)
Ca (advanced)
Ca (advanced)
Ca (advanced)
Ca (advanced)
Ca (advanced)
Ca (advanced)
Ca (advanced)
Ca (advanced)
Ca (advanced)
Ca (advanced)
Ca (advanced)
Ca (advanced)
Ca (advanced)
Ca (advanced)
Ca (advanced)
Ca (advanced)
Ca (advanced)
Ca (early)
Ca (advanced)
Ca (advanced)
Ca (advanced)
Ca (advanced)
Ca (advanced)
Leiomyosarcoma (advanced)
Adenocarcinoma (advanced)
Adenocarcinoma (advanced)
RRscm
0-86
0-83
0 79
0-86
0-91
0 79
0-66
0-67
0-86
0-68
0 70
0-85
0-69
0 90
0-71
0 85
0-88
0-85
0-84
0-80
0 75
0-72
0 79
0 93
0-69
0 89
0-89
0-71
0 77
0-87
0-86
0.99
0-76
TABLE II.-SCM Response of Lympho-
cytes from Patients with Non-malignant
Diseases and Healthy Donors
Case
No.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
Age
26
28
28
37
64
27
28
28
29
20
34
34
35
54
60
6
9
40
63
49
26
25
70
28
23
52
32
Sex
M
M
M
F
M
M
M
M
M
M
F
F
M
M
F
M
M
F
M
F
M
F
M
F
F
M
F
Diagnosis
Healthy
Healthy
Healthy
Healthy
Healthy
Healthy
Healthy
Healthy
Healthy
Healthy
Healthy
Healthy
Healthy
Healthy
Healthy
Schilder's disease
Schilder's disease
Acute hepatitis
Acute hepatitis
Cholelithiasis
Pregnancy (34 weeks)
Pregnancy (28 weeks)
Lymphadenitis
Systemic lupus erythe-
matosus
Systemic lupus erythe-
matosus
Rheumatoid arthritis
Iron deficiency anaemia
RRscM
1-50
1-32
1-31
1 -55
1-49
1-50
1-40
1-40
1 -20
1-21
1 -32
1 -08
1 -29
1-10
1-10
1 -23
1-55
1 .55
1-32
1 .59
1 -34
1-41
1 31
1 -06
1 -29
1-24
1 -08
CaBP preparation. The first series of
experiments was performed using a pre-
paration obtained from a colon cancer.
Results with new CaBP preparations
from a case of gastric cancer gave smaller
"stimulation".
The results of the first part of the
study are shown in Tables I and II
and the Figure, those of the second in
Table III.
The mean value (P) of the SCM of
unstimulated (control) lymphocytes from
healthy donors was 0-236 ± 0023, from
patients with non-malignant disorders,
0244 i 0O026, and from patients with
malignant disorders, 0-241 0028. Lym-
phocytes from healthy donors and patients
with non-malignant diseases responded
to PHA stimulation with decrease in
the SCM to an average of 75% of control
values. In contrast, lymphocytes from
patients with malignant diseases either
did not respond to PHA stimulation, or
Case
No.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
54
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FiG. Distribution of RRscM(PcaBP/PPHA) for 39
cases ofmalignancy other than stomach cancer.
showed a < 5%, decrease in the SCM
value. Lymphocytes from healthy donors
and from patients with non-malignant
disorders did not respond to CaBP, even
after up to 180 min of incubation. In
contrast, lymphocytes from patients with
malignant disorders responded to CaBP
with an average decrease in the SCM
of 20%. Changes in the SCM response
of lymphocytes to CaBP and PHA are
presented as the SCM response ratio:
RRscM PCaBP/PPHA (Cercek et al.,
1974). The RRscM values in lymphocytes
from healthy donors and patients with
non-malignant diseases range from 1-06
to 1-55 and for all patients with cancer
from 0-66 to 0-99. Details of 33 patients
with gastric cancer are presented in
Table I. The results obtained with 39
cases of other malignant disorders (viz.
cancers of the oesophagus, duodenum,
colon, gall bladder, common bile duct,
pancreas, larynx, lung and breast) are
summarized as an RRSCM histogram in
the Figure. Details for healthy donors
and patients with non-malignant dis-
orders are described in Table II, for the
10 cases of early cancer in Table III.
These pilot investigations indicate the
usefulness of the SCM test for early
diagnosis of cancer, and we are now
collecting further cases for the quantita-
tive evaluation of the accuracy of the
test.
We are obliged to Drs L. and B.
Cercek of the Paterson Laboratories,
Christie Hospital and Holt Radium Insti-
tute, Manchester, England for technical
information and advice on the SCM
technique.
We thank the surgeons of the Second
Department of Surgery, Faculty of Medi-
cine, University of Tokyo for their
collaboration.
TABLE III.-RRsCM of Lymphocytes and Histological Findings of Early-Stage Cancer of
Age
35
43
48
57
67
28
42
81
50
68
Sex
M
F
M
M
M
M
F
F
F
F
Histological diagnosis
Adenoca. mucocellulare
et microtubulare
Adenoca. mucocellulare
Adenoca. mucocellulare
Adenoca. tubulare
Adenoca. tubulare
A denoca. mucocellulare
Adenoca. mucocellulare
Adenoca. tubulare
Adenoca. tubulare
Adenoca. tubulare
the Stomach
Size of Invasio
tumour limited
(cm) to
2*5x1*0 Mucosa
3.5x 1.5
1 8x 1-6
0 8 X I
-4
{2 *0 X 0 8\t
025x3.5 2 5x3 5
10.5x5.5*
1 2x2 5
6-0x 7-Ot
2-5x2 0
Submucosa
Mucosa
Mucosa
Mucosa
Mucosa
Mucosa
Mucosa
Mucosa
Mucosa
Normal and non-malignant (26 cases)
* Double cancer.
t Superficial infiltration confined to mucosa.
Permeation to Lymph
n node
i Lymph meta-
vessel Vein stasis
+
RRscM
0-86
0-83
0-82
0-86
- - - 0-91
_- - 0-83
0-91
- - - 0-79
- - - 0-81
- - - 0-73
1-33
+0-14
Case
No.
1
2
3
4
5
6
7
8
9
10
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